Chronic antagonism of the mineralocorticoid receptor ameliorates hypertension and end organ damage in a rodent model of salt-sensitive hypertension.
about
Mineralocorticoid receptors in vascular disease: connecting molecular pathways to clinical implications.Systems pharmacology exploration of botanic drug pairs reveals the mechanism for treating different diseases.Smooth muscle cell mineralocorticoid receptors: role in vascular function and contribution to cardiovascular disease.An integrin antagonist (MK-0429) decreases proteinuria and renal fibrosis in the ZSF1 rat diabetic nephropathy model.Inhibition of local aldosterone by eplerenone reduces renal structural damage in a novel model of chronic cyclosporine A nephrotoxicity.
P2860
Chronic antagonism of the mineralocorticoid receptor ameliorates hypertension and end organ damage in a rodent model of salt-sensitive hypertension.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Chronic antagonism of the mine ...... f salt-sensitive hypertension.
@en
Chronic antagonism of the mine ...... f salt-sensitive hypertension.
@nl
type
label
Chronic antagonism of the mine ...... f salt-sensitive hypertension.
@en
Chronic antagonism of the mine ...... f salt-sensitive hypertension.
@nl
prefLabel
Chronic antagonism of the mine ...... f salt-sensitive hypertension.
@en
Chronic antagonism of the mine ...... f salt-sensitive hypertension.
@nl
P2093
P2860
P1476
Chronic antagonism of the mine ...... f salt-sensitive hypertension.
@en
P2093
Amy M Flattery
Daphne Szeto
Gail Forrest
Huawei Zhao
Martin F Crook
Michael J Forrest
Olga Urosevic-Price
Sophie Roy
Wanda Sharif-Rodriguez
P2860
P304
P356
10.3109/10641963.2011.566956
P577
2011-09-27T00:00:00Z